David Erritzoe

Dr David Erritzoe is a clinical associate professor in psychopharmacology and psychiatry and Director of Imperial College’s Centre Psychedelic Research and the associated NHS-based CIPPRes Clinic. Here, he leads psychopharmacological and clinical research into the neurobiological underpinnings – e.g. using PET, fMRI and/or EEG brain imaging – of mental health conditions such as depression and addictions. Much of his work focuses on the therapeutic effects and associated neuromechanisms of psychedelic compounds. David has published 150+ scientific papers and is among the most cited scientists globally (top 0.1% in 2025, Clarivate), and in 2025 received Imperial’s President Award for Excellence in Research.